Yehia Hashad
CIK 1877701 · EVP of R&D and CMO · last filed 2026-05-07
Yehia Hashad is an EVP of R&D and CMO who has filed 19 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing shows the insider had shares withheld for taxes covering $218.6K of BLCO on May 7, 2026. Current disclosed insider exposure totals $2.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.51M
3
19
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BLCO | EVP of R&D and CMO | 166,377 | $15.08 | $2.51M | $0 | 15 | 2026-05-07 |
| Unity Biotechnology, Inc. (UBX) Delisted | Director | — | $0.20 | — | $0 | 1 | 2025-03-10 |
| APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Director | — | $0.39 | — | $0 | 3 | 2022-12-01 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-07 | BLCO | Tax (F) | −13,664 | -$218.6K | EDGAR |
| 2026-03-02 | BLCO | Tax (F) | −18,865 | -$345.6K | EDGAR |
| 2026-02-27 | BLCO | Grant (A) | +35,046 | $0 | EDGAR |
| 2026-02-20 | BLCO | Grant (A) | +29,406 | $0 | EDGAR |
| 2025-08-07 | BLCO | Grant (A) | +17,715 | $0 | EDGAR |
| 2025-07-28 | BLCO | Tax (F) | −2,841 | -$40.7K | EDGAR |
| 2025-03-10 | Unity Biotechnology, Inc. (UBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-02-28 | BLCO | Grant (A) | +25,225 | $0 | EDGAR |
| 2024-12-26 | BLCO | Tax (F) | −5,075 | -$90.5K | EDGAR |
| 2024-07-29 | BLCO | Tax (F) | −2,841 | -$44.1K | EDGAR |